Position in ATYR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,080,277
-$3,117,271 QoQ
Shares Held
8,509,678
-19.0% QoQ
Ownership
8.68%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 90 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. ATYR ranks #69 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in ATYR
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,080,277 | 8,509,678 | Shares | Sole | 2026-07-08 | |
| 2026-06-30 | $5,080,277 | 8,509,678 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $8,197,548 | 10,509,678 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $8,229,077 | 10,509,678 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $7,602,539 | 10,544,437 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $74,359,662 | 14,666,600 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $44,293,132 | 14,666,600 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $53,093,092 | 14,666,600 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $25,813,216 | 14,666,600 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,879,896 | 14,666,600 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $19,830,720 | 10,169,600 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $14,339,136 | 10,169,600 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $16,067,968 | 10,169,600 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $22,010,326 | 10,189,966 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,398,928 | 10,189,966 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $11,457,204 | 5,231,600 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,666,750 | 5,222,250 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,778,967 | 5,222,250 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $27,939,037 | 5,222,250 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $39,010,207 | 5,222,250 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $47,418,030 | 5,222,250 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,881,200 | 1,615,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,186,750 | 1,615,000 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $6,266,200 | 1,615,000 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,216,450 | 1,615,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,170,600 | 1,615,000 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,522,000 | 1,615,000 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||